"We believe the outcomes of life-changing medical procedures shouldn’t be reliant on guesswork. The Stelect technology takes the guesswork out of coronary stent selection.”

- Elise Sutherland, CEO



Elise is a biomedical engineer, entrepreneur, speaker and women in STEM advocate. Elise is passionate about improving health outcomes for patients whilst simultaneously making technology more affordable for the healthcare system. Elise founded Stelect as she has witnessed firsthand the issues arrising with being reliant on guess-work in coronary stenting procedures. 

Stelect is a multi award-winning Melbourne-based innovative medical device company developing a novel imaging solution to aid clinicians with the process of selecting stents for patients suffering from coronary heart blockage.


We're aiming to create better health outcomes for patients requiring stenting procedures as well as uplifting the outdated technology by introducing our novel and affordable imaging solution.


Our patented technology, an ultrasound imaging balloon catheter, has already received praise and approval by interventional cardiologists as well as winning us numerous awards and recognition from the biggest MedTech and Venture Capitalist firms, globally.


We are the winners of the 2017 Ernst & Young Survive the Panel Startup Competition, and additionally, we were voted to win the People's Choice Award.


We are the grand prize winners of the 2017/18 MedTech's Got Talent Competition, Australia's largest national MedTech startup competition, and were deemed the most investible startup out of over 200 applications. Our award-winning technology has also received recognition from the Chinese market as the runner-up of the 2018 Sunan Cup Startup Competition.


Stelect joined The Actuator, Australia’s National MedTech accelerator, in July 2018 to guide us on our commercialisation journey.


Stelect has now closed two rounds of funding and are looking forward to our Series A raise in mid 2020. 




Percutaneous Coronary Intervention, or PCI, is the current method for assessing coronary artery blockages and selecting the optimal stent to implant to keep an artery open and blood flowing.


When performing PCI procedures, clinicians are limited to only an external view of the blocked artery. This gives clinicians limited information to make blockage evaluations and to determine the correct stent to implant.

The Stelect technology aims to change this. We are introducing a pre-stent balloon catheter that utilises ultrasound technology to provide clinicians with a complete inside-out 3D visualisation of the blocked artery as well as in-depth data regarding blockage measurements and morphology, information vital to stent selection.


This technology will enable clinicians to base their stent selections on hard evidence and not guesswork.



Stelect is proud to be in partnerships with the following Investment Firms and Consulting Companies.

Get in touch with us today if you like to discuss our partnership opportunities.

Procept Investor Partner Supporter MedTech Medical Device
Artesian Finance Investor Partner Supporter MedTech Medical Device
K&L Gates Investor Partner Legal Law Firm Supporter MedTech Medical Device


  • LinkedIn Social Icon
  • Twitter Social Icon

Goods Shed North, 710 Collins St, Docklands, VIC 3008